PRCS Message Board - Msg: 16426443

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PRCS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: XenaLives who wrote (47)	9/28/2001 9:43:44 AM
From: tuck	Read Replies (1) of 78

>>WALTHAM, Mass. (Reuters) - Praecis Pharmaceuticals Inc. (NasdaqNM:PRCS - news) said on Friday it would not proceed with more trials of its back pain drug Latranal because the product was not effective in Phase II clinical trials. The Waltham, Massachusetts-based company also said it is conducting Phase III tests of its prostate cancer drug Plenaxis. Praecis said it has gathered 40 subjects to begin Phase I testing of its Alzheimer's disease drug Apan.<< snip Frankly, I didn't expect Latranal to work, and am glad they are doing this. How the Street takes it may be another matter. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next